MODERATE risk dossiers
Moderate-risk compounds requiring protocol governance and specialist oversight.
Neuropeptide
Melanotan III
Second-generation melanocortin analog pairing pigmentation control with neuromodulatory appetite regulation.
GLP-1
Compound 61398
GLP-1 candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Small Molecule
Compound 61399
Small Molecule candidate engineered for cellular repair initiatives with automated dossier coverage.
Thyroid Analog
Compound 61401
Thyroid Analog candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Androgen Modulator
Compound 61402
Androgen Modulator candidate engineered for endocrine support initiatives with automated dossier coverage.
Mitochondrial Peptide
Compound 61403
Mitochondrial Peptide candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Small Molecule
Compound 61406
Small Molecule candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Neuropeptide
Compound 61407
Neuropeptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Thyroid Analog
Compound 61408
Thyroid Analog candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Androgen Modulator
Compound 61409
Androgen Modulator candidate engineered for cellular repair initiatives with automated dossier coverage.
Peptide
Compound 61411
Peptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
GLP-1
Compound 61412
GLP-1 candidate engineered for endocrine support initiatives with automated dossier coverage.
Small Molecule
Compound 61413
Small Molecule candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Neuropeptide
Compound 61414
Neuropeptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Androgen Modulator
Compound 61416
Androgen Modulator candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Mitochondrial Peptide
Compound 61417
Mitochondrial Peptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Peptide
Compound 61418
Peptide candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
GLP-1
Compound 61419
GLP-1 candidate engineered for cellular repair initiatives with automated dossier coverage.
Thyroid Analog
Compound 61422
Thyroid Analog candidate engineered for endocrine support initiatives with automated dossier coverage.
Androgen Modulator
Compound 61423
Androgen Modulator candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Mitochondrial Peptide
Compound 61424
Mitochondrial Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
GLP-1
Compound 61426
GLP-1 candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Small Molecule
Compound 61427
Small Molecule candidate engineered for endocrine support initiatives with automated dossier coverage.
Neuropeptide
Compound 61428
Neuropeptide candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Thyroid Analog
Compound 61429
Thyroid Analog candidate engineered for cellular repair initiatives with automated dossier coverage.
Mitochondrial Peptide
Compound 61431
Mitochondrial Peptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Peptide
Compound 61432
Peptide candidate engineered for endocrine support initiatives with automated dossier coverage.
GLP-1
Compound 61433
GLP-1 candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Small Molecule
Compound 61434
Small Molecule candidate engineered for cellular repair initiatives with automated dossier coverage.
Thyroid Analog
Compound 61436
Thyroid Analog candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Androgen Modulator
Compound 61437
Androgen Modulator candidate engineered for endocrine support initiatives with automated dossier coverage.
Peptide
Compound 61439
Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Small Molecule
Compound 61441
Small Molecule candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Neuropeptide
Compound 61442
Neuropeptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Thyroid Analog
Compound 61443
Thyroid Analog candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Androgen Modulator
Compound 61444
Androgen Modulator candidate engineered for cellular repair initiatives with automated dossier coverage.
Peptide
Compound 61446
Peptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
GLP-1
Compound 61447
GLP-1 candidate engineered for endocrine support initiatives with automated dossier coverage.
Small Molecule
Compound 61448
Small Molecule candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Neuropeptide
Compound 61449
Neuropeptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Androgen Modulator
Compound 61451
Androgen Modulator candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Mitochondrial Peptide
Compound 61452
Mitochondrial Peptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Peptide
Compound 61453
Peptide candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
GLP-1
Compound 61454
GLP-1 candidate engineered for cellular repair initiatives with automated dossier coverage.
Neuropeptide
Compound 61456
Neuropeptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Thyroid Analog
Compound 61457
Thyroid Analog candidate engineered for endocrine support initiatives with automated dossier coverage.
Androgen Modulator
Compound 61458
Androgen Modulator candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Mitochondrial Peptide
Compound 61459
Mitochondrial Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.